EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Diagnostic value of dd-cfDNA and CXCL-10 in kidney allograft recipients for identifying acute rejection

Qi Yu, Yan Zhang, Zijian Gao, Boqian Wang, Hongwei Yang, Long He

Transplant Immunology · 2025

DOI: 10.1016/j.trim.2025.102307 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant Immunology, 2025. Verfasst von Qi Yu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research and Training, General Hospital of Northern Theater Command, Shenyang 110016, China. Hauptthemen laut MEDLINE: Kidney Transplantation, Chemokine CXCL10, Graft Rejection, Cell-Free Nucleic Acids. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Department of Science and Technology of Liaoning Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND HYPOTHESIS: Acute rejection (AR) remains a major challenge in kidney transplantation. Current methods used to diagnose acute rejection are either invasive or not sufficiently sensitive. Thus, in this study, we aimed to develop a novel and sensitive diagnostic tool for predicting acute rejection after kidney transplantation. We investigated if donor-derived cell-free DNA (dd-cfDNA) in the serum and C-X-C motif chemokine 10 (CXCL-10) levels were closely related to the occurrence of AR after renal transplantation. METHODS: We collected data and tested the serum levels of dd-cfDNA and CXCL-10 in AR patients and patients who underwent kidney transplantation during the same period. Logistic analysis was used to verify risk factors associated with AR. The analysis of the receiver operating characteristic curve(ROC) was used to reveal correlation between dd-cfDNA,CXCL-10 levels and AR patients. RESULTS: We included 13 AR patients and 18 patients without acute rejection. The AR group had a lower BMI (P = 0.006), and higher levels of eGFR (P = 0.006) and CysC (P = 0.009). Additionally, ln dd-cfDNA percentage and ln CXCL-10 content were higher in the AR group compared to the control group (P = 0.007, P = 0.004).The results of logistic analysis suggested CysC(OR:2.562[95 % CI:1.377-4.766],P = 0.003),ln dd-cfDNA percent (OR: 10.521 [95 % CI: 2.091-52.938],P = 0.004), and ln CXCL-10 content(OR:49.052 [95 % CI: 1.730-1391.073],P = 0.023) can indicate the risk of AR and were independently correlated with the occurrence of acute rejection of the kidney graft. The AUC of serum dd-cfDNA (AUC = 0.723, P = 0.0348) percent and CXCL-10 content (AUC = 0.814, P = 0.0029) showed significant diagnostic performance. The combined dd-cfDNA and CXCL-10 diagnosis showed higher AUC and specificity. CONCLUSIONS: Serum dd-cfDNA and CXCL-10 levels were significantly elevated in patients with acute rejection. Thus, dd-cfDNA and CXCL-10 can play suggestive roles in detecting graft injury after kidney transplantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationChemokine CXCL10Graft RejectionCell-Free Nucleic AcidsHumansMaleFemaleMiddle AgedAdultAcute DiseaseBiomarkersROC CurveRisk FactorsTransplantation, Homologous

Stichwörter der Autor:innen

Acute rejectionCXCL-10Diagnostic toolsKidney transplantationdd-cfDNA

Substanzen

Chemokine CXCL10CXCL10 protein, humanCell-Free Nucleic AcidsBiomarkers

Autor:innen und Institutionen

  • Department of Research and Training, General Hospital of Northern Theater Command, Shenyang 110016, China.
  • Department of Research and Training, General Hospital of Northern Theater Command, Shenyang 110016, China; Organ Transplant Center, General Hospital of Northern Theater Command, Shenyang 110016, China.
  • Urology, Shengyang Jinghua Hospital, Shenyang 110016, China.
  • Organ Transplant Center, General Hospital of Northern Theater Command, Shenyang 110016, China.
  • Organ Transplant Center, General Hospital of Northern Theater Command, Shenyang 110016, China. Electronic address: yang_hongwei@163.com.
  • Organ Transplant Center, General Hospital of Northern Theater Command, Shenyang 110016, China. Electronic address: helongjimmie@163.com.

Förderung

  • Department of Science and Technology of Liaoning Province

Zitieren

APA

Yu, Q., Zhang, Y., Gao, Z., Wang, B., Yang, H., & He, L. (2025). Diagnostic value of dd-cfDNA and CXCL-10 in kidney allograft recipients for identifying acute rejection. Transplant Immunology. https://doi.org/10.1016/j.trim.2025.102307

Vancouver

Yu Q, Zhang Y, Gao Z, Wang B, Yang H, He L. Diagnostic value of dd-cfDNA and CXCL-10 in kidney allograft recipients for identifying acute rejection. Transplant Immunology. 2025. doi:10.1016/j.trim.2025.102307

BibTeX
@article{Yu2025,
  author = {Yu, Qi and Zhang, Yan and Gao, Zijian and Wang, Boqian and Yang, Hongwei and He, Long},
  title = {Diagnostic value of dd-cfDNA and CXCL-10 in kidney allograft recipients for identifying acute rejection},
  journal = {Transplant Immunology},
  year = {2025},
  doi = {10.1016/j.trim.2025.102307}
}
Kostenlos starten →